Comparing QHSLab (OTCMKTS:USAQ) and Anteris Technologies Global (NASDAQ:AVR)

QHSLab (OTCMKTS:USAQGet Free Report) and Anteris Technologies Global (NASDAQ:AVRGet Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings and risk.

Profitability

This table compares QHSLab and Anteris Technologies Global’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
QHSLab -14.85% N/A -22.45%
Anteris Technologies Global -3,944.93% -252.71% -169.61%

Analyst Ratings

This is a summary of recent recommendations and price targets for QHSLab and Anteris Technologies Global, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QHSLab 0 0 0 0 0.00
Anteris Technologies Global 1 0 4 0 2.60

Anteris Technologies Global has a consensus target price of $16.50, suggesting a potential upside of 275.00%. Given Anteris Technologies Global’s stronger consensus rating and higher probable upside, analysts clearly believe Anteris Technologies Global is more favorable than QHSLab.

Valuation & Earnings

This table compares QHSLab and Anteris Technologies Global”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
QHSLab $2.13 million 2.09 -$260,000.00 ($0.04) -10.50
Anteris Technologies Global $2.70 million 67.14 -$76.29 million ($1.81) -2.43

QHSLab has higher earnings, but lower revenue than Anteris Technologies Global. QHSLab is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Summary

Anteris Technologies Global beats QHSLab on 6 of the 11 factors compared between the two stocks.

About QHSLab

(Get Free Report)

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.

About Anteris Technologies Global

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Receive News & Ratings for QHSLab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QHSLab and related companies with MarketBeat.com's FREE daily email newsletter.